187 related articles for article (PubMed ID: 8762727)
1. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
Juul A; Flyvbjerg A; Frystyk J; Müller J; Skakkebaek NE
Clin Endocrinol (Oxf); 1996 May; 44(5):515-23. PubMed ID: 8762727
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
3. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
Belgorosky A; Rivarola MA
Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.
Juul A; Fisker S; Scheike T; Hertel T; Müller J; Orskov H; Skakkebaek NE
Clin Endocrinol (Oxf); 2000 Feb; 52(2):165-72. PubMed ID: 10671943
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
Kanety H; Karasik A; Pariente C; Kauschansky A
Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
Juul A; Dalgaard P; Blum WF; Bang P; Hall K; Michaelsen KF; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Aug; 80(8):2534-42. PubMed ID: 7543116
[TBL] [Abstract][Full Text] [Related]
8. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
Cisternino M; Draghi M; Lauriola S; Scarcella D; Bernasconi S; Cavallo L; De Luca F; Lomeo A; Tatò L
J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447
[TBL] [Abstract][Full Text] [Related]
9. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
10. Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children.
Garrone S; Radetti G; Sidoti M; Bozzola M; Minuto F; Barreca A
J Clin Endocrinol Metab; 2002 Dec; 87(12):5455-60. PubMed ID: 12466336
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment.
Juul A; Müller J; Skakkebaek NE
Eur J Endocrinol; 1997 Apr; 136(4):401-5. PubMed ID: 9150700
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status.
Falorni A; Bini V; Cabiati G; Papi F; Arzano S; Celi F; Sanasi M
Metabolism; 1997 Aug; 46(8):862-71. PubMed ID: 9258266
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus.
Cinaz P; Kendirci M; Kurtoglu S; Gökçora N; Buyan N; Yavuz I; Demir A
J Pediatr Endocrinol Metab; 1996; 9(4):475-82. PubMed ID: 8910817
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
[TBL] [Abstract][Full Text] [Related]
15. The relationship between ovarian structure and serum insulin, insulin-like growth factor-I (IGF-I) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche.
Teixeira RJ; Silva VC; Gazolla HM; Cunha SB; Guimarães MM
J Pediatr Endocrinol Metab; 2002 Jan; 15(1):69-75. PubMed ID: 11826868
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the GH/IGF-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal boys.
Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
J Clin Endocrinol Metab; 2002 Mar; 87(3):1162-9. PubMed ID: 11889181
[TBL] [Abstract][Full Text] [Related]
17. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty.
Bereket A; Turan S; Omar A; Berber M; Ozen A; Akbenlioglu C; Haklar G
Horm Res; 2006; 65(2):96-105. PubMed ID: 16462144
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche.
Sales DS; Moreira AC; Camacho-Hübner C; Ricco RG; Daneluzzi JC; Campos AD; Martinelli CE
J Pediatr Endocrinol Metab; 2003; 16(6):827-33. PubMed ID: 12948294
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factors, insulin-like growth factor-binding proteins, insulin-like growth factor-binding protein-3 protease, and growth hormone-binding protein in lipodystrophic human immunodeficiency virus-infected patients.
Haugaard SB; Andersen O; Hansen BR; Orskov H; Andersen UB; Madsbad S; Iversen J; Flyvbjerg A
Metabolism; 2004 Dec; 53(12):1565-73. PubMed ID: 15562401
[TBL] [Abstract][Full Text] [Related]
20. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
Tatò L; Saggese G; Cavallo L; Antoniazzi F; Corrias A; Pasquino AM; Cisternino M
Horm Res; 1995; 44 Suppl 3():49-54. PubMed ID: 8719441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
